Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2014

01.05.2014 | Pancreatic Tumors

Comparison of Preoperative Conference-Based Diagnosis with Histology of Cystic Tumors of the Pancreas

verfasst von: Marco Del Chiaro, MD, PhD, Ralf Segersvärd, MD, PhD, Raffaella Pozzi Mucelli, MD, Elena Rangelova, MD, Nikolaos Kartalis, MD, PhD, Christoph Ansorge, MD, PhD, Urban Arnelo, MD, PhD, John Blomberg, MD, PhD, Matthias Löhr, MD, PhD, Caroline Verbeke, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Diagnostic errors in the evaluation of cystic neoplasms of the pancreas (PCNs) are quite common. Few data are available regarding the impact of these errors on clinical management. The aim of this study was to determine the accuracy of a pancreatic multidisciplinary conference in diagnosing PCNs, to assess the potential risk of misdiagnosis, and to evaluate the clinical impact of these errors.

Methods

A retrospective consecutive series of patients undergoing surgery for PCNs at Karolinska University Hospital between 2004 and 2012 was analyzed.

Results

During the study period, a total of 141 patients had undergone pancreatic resection for PCN. The overall accuracy of the preoperative diagnosis was 60.9 %. The rate of concordance between preoperative diagnosis and histology was similar for asymptomatic and symptomatic lesions (62.8 vs. 59.1 %; p = NS). The rate of correct diagnosis increased over time (54.5 % in 2004–2006, 61.7 % in 2007–2012, 63.5 % in 2010–2012). Univariate analysis identified the location of the lesion (diffuse pancreatic involvement) and a mucinous nature of the lesion as factors conducive to a correct diagnosis. Reevaluation of the original indication for surgery in light of the exact diagnosis showed that a surgical procedure should not have been performed in 12 patients (8.5 %).

Conclusions

This study confirms that diagnostic errors are fairly common in the preoperative assessment of PCNs, but the errors are clinically relevant in <10 % of patients.
Literatur
1.
Zurück zum Zitat Correa-Gallego C, Ferrone CR, Thayer SP, et al. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology. 2010;10:144–50.PubMedCentralPubMedCrossRef Correa-Gallego C, Ferrone CR, Thayer SP, et al. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology. 2010;10:144–50.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Ip IK, Mortele KJ, Prevedello LM, et al. Focal cystic pancreatic lesions: assessing variation in radiologists management recommendations. Radiology. 2011;259:136–41.PubMedCrossRef Ip IK, Mortele KJ, Prevedello LM, et al. Focal cystic pancreatic lesions: assessing variation in radiologists management recommendations. Radiology. 2011;259:136–41.PubMedCrossRef
4.
Zurück zum Zitat Zhang XM, Mitchell DG, Dohke M, et al. Pancreatic cysts: detection on single-shot fast spin-echo MR images. Radiology. 2002;223:547–53.PubMedCrossRef Zhang XM, Mitchell DG, Dohke M, et al. Pancreatic cysts: detection on single-shot fast spin-echo MR images. Radiology. 2002;223:547–53.PubMedCrossRef
5.
Zurück zum Zitat Del Chiaro M, Verbeke C, Salvia R, et al. European experts consensus steatment on cystic tumors of the pancreas. Dig Liver Dis. 2013;45(9):703–11. Del Chiaro M, Verbeke C, Salvia R, et al. European experts consensus steatment on cystic tumors of the pancreas. Dig Liver Dis. 2013;45(9):703–11.
6.
Zurück zum Zitat Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97.CrossRef Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97.CrossRef
7.
Zurück zum Zitat Cho CS, Russ AJ, Loeffler AG, et al. Preoperative classification of pancreatic cystic neoplasms: the clinical significance of diagnostic inaccuracy. Ann Surg Oncol. 2013;20(9):3112–9. Cho CS, Russ AJ, Loeffler AG, et al. Preoperative classification of pancreatic cystic neoplasms: the clinical significance of diagnostic inaccuracy. Ann Surg Oncol. 2013;20(9):3112–9.
8.
Zurück zum Zitat Salvia R, Malleo G, Marchegiani G, et al. Pancreatic resections for cystic neoplasm: from the surgeon’s presumption to the pathologist’s reality. Surgery. 2012;152:S135–42.PubMedCrossRef Salvia R, Malleo G, Marchegiani G, et al. Pancreatic resections for cystic neoplasm: from the surgeon’s presumption to the pathologist’s reality. Surgery. 2012;152:S135–42.PubMedCrossRef
9.
Zurück zum Zitat Leung KK, Ross WA, Evans D, et al. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann Surg Oncol. 2009;16:2818–24.PubMedCrossRef Leung KK, Ross WA, Evans D, et al. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann Surg Oncol. 2009;16:2818–24.PubMedCrossRef
10.
Zurück zum Zitat Donahue TR, Hines OJ, Farrell JJ. Cystic neoplasms of the pancreas: results of 114 cases. Pancreas. 2010;39:1271–6.PubMedCrossRef Donahue TR, Hines OJ, Farrell JJ. Cystic neoplasms of the pancreas: results of 114 cases. Pancreas. 2010;39:1271–6.PubMedCrossRef
11.
Zurück zum Zitat Bosman F, Carneiro F, Hruban R, Theise N, editors. WHO classification of tumors of the digestive system. 4th ed. Lyon: IARC Press; 2010. Bosman F, Carneiro F, Hruban R, Theise N, editors. WHO classification of tumors of the digestive system. 4th ed. Lyon: IARC Press; 2010.
12.
Zurück zum Zitat Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRef Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRef
13.
Zurück zum Zitat Tseng JF, Warshaw AL, Sahani DV, et al. Serous cystadenoma of the pancreas: tumor grow rates and recommendations for treatment. Ann Surg. 2005;242:413–9.PubMedCentralPubMed Tseng JF, Warshaw AL, Sahani DV, et al. Serous cystadenoma of the pancreas: tumor grow rates and recommendations for treatment. Ann Surg. 2005;242:413–9.PubMedCentralPubMed
14.
Zurück zum Zitat Malleo G, Bassi C, Rossini R, et al. Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment. Gut. 2011;61(5):746–51.PubMedCrossRef Malleo G, Bassi C, Rossini R, et al. Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment. Gut. 2011;61(5):746–51.PubMedCrossRef
15.
Zurück zum Zitat Tipton SG, Smyrk TC, Sarr MG, et al. Malignant potential of solid pseudopapillary neoplasm of the pancreas. Br J Surg. 2006;93:733–7.PubMedCrossRef Tipton SG, Smyrk TC, Sarr MG, et al. Malignant potential of solid pseudopapillary neoplasm of the pancreas. Br J Surg. 2006;93:733–7.PubMedCrossRef
16.
Zurück zum Zitat Allen PJ, Jaques DP, D’Angelica M, et al. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg. 2003;7:970–7.PubMedCrossRef Allen PJ, Jaques DP, D’Angelica M, et al. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg. 2003;7:970–7.PubMedCrossRef
17.
Zurück zum Zitat Ryu JK, Woo SM, Hwang JH, et al. Cyst fluid analysis for the differential diagnosis of pancreatic cysts. Diagn Cytopathol. 2004;31:100–5.PubMedCrossRef Ryu JK, Woo SM, Hwang JH, et al. Cyst fluid analysis for the differential diagnosis of pancreatic cysts. Diagn Cytopathol. 2004;31:100–5.PubMedCrossRef
18.
Zurück zum Zitat Jang JY, Kim SW, Lee SE, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol. 2008;15:199–205.PubMedCrossRef Jang JY, Kim SW, Lee SE, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol. 2008;15:199–205.PubMedCrossRef
19.
Zurück zum Zitat Allen PJ, D’Angelica M, Gonen M, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 2006;244:572–82.PubMedCentralPubMed Allen PJ, D’Angelica M, Gonen M, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 2006;244:572–82.PubMedCentralPubMed
20.
Zurück zum Zitat Ahmad NA, Kochman ML, Bernsinger C, et al. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc. 2003;58:59–64.PubMedCrossRef Ahmad NA, Kochman ML, Bernsinger C, et al. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc. 2003;58:59–64.PubMedCrossRef
21.
Zurück zum Zitat Cizniger S, Turner B, Bilge AR, et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas. 2011;40:1024–8.CrossRef Cizniger S, Turner B, Bilge AR, et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas. 2011;40:1024–8.CrossRef
Metadaten
Titel
Comparison of Preoperative Conference-Based Diagnosis with Histology of Cystic Tumors of the Pancreas
verfasst von
Marco Del Chiaro, MD, PhD
Ralf Segersvärd, MD, PhD
Raffaella Pozzi Mucelli, MD
Elena Rangelova, MD
Nikolaos Kartalis, MD, PhD
Christoph Ansorge, MD, PhD
Urban Arnelo, MD, PhD
John Blomberg, MD, PhD
Matthias Löhr, MD, PhD
Caroline Verbeke, MD, PhD
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2014
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3465-9

Weitere Artikel der Ausgabe 5/2014

Annals of Surgical Oncology 5/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.